P. Andrews

J. Cameron, K. Warr, J. Hicks, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Tumor necrosis factor α blockade with infliximab for refractory uveitis and scleritis

D. Jayne, C. Murphy, P. Andrews, 2004 .

Expression and tissue localization of donor‐specific complement C3 synthesized in human renal allografts

P. Mathieson, Wuding Zhou, S. Sacks, 1995, European journal of immunology.

Summary of the British Transplantation Society/Renal Association U.K. guidelines for living donor kidney transplantation.

J. Bradley, C. Dudley, D. Manas, 2012, Transplantation.

Renal disease and use of topical non-steroidal: anti-inflammatory drugs

C. O'Callaghan, P. Andrews, C. Ogg, 1994, BMJ.

AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: a report of two cases.

P. Hawkins, D. Rowczenio, H. Lachmann, 2006, Arthritis and rheumatism.

Outcome of transplantation of non-heart-beating donor kidneys.

M. Denton, P. Andrews, F. Compton, 1995, Lancet.

Renal failure in a patient with chronic myelomonocytic leukaemia.

D. Bevan, K. Sundaram, P. Andrews, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Renal transplantation

P. Andrews, 2002, BMJ : British Medical Journal.

Safety and efficacy of TNFalpha blockade in relapsing vasculitis.

D. Jayne, P. Andrews, H. Jefferson, 2002, Annals of the rheumatic diseases.

Early identification and management of chronic kidney disease in adults in primary and secondary care: a commentary on NICE Guideline No 73, Sept 2008

P. Andrews, 2008 .

Evidence for increased synthesis of complement C4 in the renal epithelium of rats with passive Heymann nephritis.

P. Verroust, S. Sacks, B. Hartley, 1997, Journal of the American Society of Nephrology : JASN.

Local transcription of complement C3 in human allograft rejection. Evidence for a pathogenic role and correlation to histology and outcome.

A. Pani, S. Sacks, P. Andrews, 1994, Transplantation.

Endogenous complement C3 synthesis in immune complex nephritis

S. Sacks, B. Hartley, P. Andrews, 1993, The Lancet.

Cytomegalovirus Infection and Abdominal Pain with Mycophenolate Mofetil

H. Gallagher, P. Andrews, 2001, Drug safety.

Anti-glomerular basement membrane antibody-mediated nephritis: when not to treat.

P. Andrews, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Risk of pneumonia after hospital treatment for pneumonia

J. Giesecke, J. Hedlund, M. Kalin, 1992, The Lancet.

Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.

D. Jayne, C. Murphy, P. Andrews, 2004, Ophthalmology.

The asystolic donor syndrome: transaminitis and thrombocytopenia after non-heartbeating renal transplantation.

M. Denton, P. Andrews, F. Compton, 1997, Transplantation.

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients

J. Popoola, I. Macphee, M. Phanish, 2020, BMC Nephrology.

A report on the activity and clinical outcomes of renal non‐heart beating donor transplantation in the United Kingdom

M. Nicholson, N. Brook, P. Andrews, 2004, Clinical transplantation.

Racial variation in dosage requirements of tacrolimus

P. Andrews, R. Chang, M. Sen, 1996, The Lancet.

A painful skin rash in a patient with Stage V chronic kidney disease

A. Meyrier, P. Andrews, K. Shiell, 2011, NDT plus.

Successful pregnancy in cystinosis.

S. Sacks, P. Andrews, W. V. van’t Hoff, 1994, JAMA.

Summary of the British Transplantation Society Guidelines for the Prevention and Management of CMV Disease After Solid Organ Transplantation.

V. Emery, C. Newstead, P. Andrews, 2011, Transplantation.

Summary of the British Transplantation Society UK Guidelines for Hepatitis E and Solid Organ Transplantation.

R. Tedder, A. Elsharkawy, M. Ankcorn, 2018, Transplantation.

Rhesus immunization after renal transplantation.

S. Sacks, A. Payne, P. Andrews, 1996, Transplantation.

British Transplantation Society / Renal Association UK Guidelines for Living Donor Kidney Transplantation 2018: Summary of Updated Guidance.

P. Andrews, L. Burnapp, 2018, Transplantation.

Transplant: From Myth to Reality

Peter A Andrews, Nicholas L Tilney, P. Andrews, 2003, BMJ : British Medical Journal.

Summary of the British Transplantation Society Guidelines for Management of the Failing Kidney Transplant.

P. Andrews, 2014, Transplantation.

Inflammatory periodontal disease as a potential marker of cardiovascular risk.

P. Andrews, 2005, Transplantation.

Tissue synthesis of complement as an immune regulator.

Wuding Zhou, S. Sacks, P. Andrews, 1995, Molecular medicine today.

Kidney donation after paracetamol overdose.

P. Andrews, C. G. Koffman, 1993, BMJ.

Acute interstitial nephritis associated with Mycoplasma pneumoniae infection.

S. Sacks, C. Lloyd, P. Andrews, 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Unusual presentations of anti-glomerular basement membrane antibody mediated disease are associated with delayed diagnosis and poor outcome.

S. Sacks, J. Hicks, P. Andrews, 1995, Clinical nephrology.

Renal transplantation in a patient with loin pain hematuria syndrome.

P. Andrews, R. Diwakar, 2006, Clinical nephrology.

Topical non-steroidal drugs are systemically absorbed and may cause renal disease.

P. Andrews, S. Sampson, Peter A Andrews, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Outcome of renal allografts from non-heart-beating donors with delayed graft function

V. Papalois, P. Andrews, C. Gerstenkorn, 2002, Transplant international : official journal of the European Society for Organ Transplantation.

Not yet time for a paradigm shift away from angiotensin inhibitors in chronic kidney disease, but due diligence required

P. Andrews, P. Swift, 2010, International journal of clinical practice.

Cervical myxofibrosarcoma in a renal allograft recipient treated with murine anti-CD3 monoclonal antibody therapy.

P. Andrews, M. Bending, C. Soper, 1998, Nephrology, Dialysis and Transplantation.

Metformin in advanced chronic kidney disease: are current guidelines overly restrictive?

P. Andrews, N. Cole, P. Swift, 2016 .

Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis

M. Allison, G. Auzinger, J. Neuberger, 2012, Gut.

Mucormycosis in transplant recipients: possible case-case transmission and potentiation by cytomegalovirus.

C. Ogg, P. Andrews, D. Williams, 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Intravascular Haemolysis and Interstitial Nephritis in Association with Ciprofloxacin

P. Andrews, Grant T. Robinson, 1999, Nephron.

Summary of the British Transplantation Society UK Guidelines for Living Donor Liver Transplantation.

D. Manas, P. Andrews, L. Burnapp, 2016, Transplantation.

A rare and reversible cause of anaemia and renal impairment

M. Phanish, P. Andrews, 2006, The Lancet.

Interactions with ciprofloxacin and aminophylline toxicity

P. Andrews, 1998 .

Interactions with ciprofloxacin and erythromycin leading to aminophylline toxicity.

P. Andrews, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Recurrence of lipoprotein glomerulopathy after renal transplantation.

M. Bewick, S. Snowden, P. Andrews, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Mycophenolate Mofetil for Remission Induction in Severe Lupus Nephritis

P. Mathieson, D. Jayne, Á. Burns, 2005, Nephron Clinical Practice.

MOLECULAR ANALYSIS OF C3 ALLOTYPES RELATED TO TRANSPLANT OUTCOME IN HUMAN RENAL ALLOGRAFTS

P. Mathieson, S. Sacks, P. Andrews, 1995, Transplantation.

Antiphospholipid syndrome and systemic lupus erythematosus

G. Frampton, J. Cameron, P. Andrews, 1993, The Lancet.

NICE guidelines: renal disease — prevention and early management

P. Andrews, 2002 .

Renal transplantation in Wiskott-Aldrich syndrome.

J. Cameron, P. Andrews, M. Webb, 1993, Transplantation.

Outcome of renal transplantation in Wiskott-Aldrich syndrome.

P. Andrews, C. G. Koffman, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Outcome of renal allografts from non‐heart‐beating donors with delayed graft function

V. Papalois, P. Andrews, C. Gerstenkorn, 2002 .

Ondansetron for symptomatic relief in terminal uraemia.

C. Ogg, P. Andrews, V. Quan, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Use of Ondansetron, a New Antiemetic, in Uremia

P. Andrews, 1995 .

Summary of the British Transplantation Society guidelines for transplantation from donors after deceased circulatory death.

D. Manas, P. Andrews, L. Burnapp, 2014, Transplantation.

Lipoprotein glomerulopathy: a new cause of nephrotic syndrome after renal transplantation. Implications for renal transplantation.

P. Andrews, 1999, Nephrology, Dialysis and Transplantation.

Guidelines are not perfect but provide safeguards for both patients and physicians

P. Andrews, 2019, BMJ.

NSAIDS in the postoperative period. Many factors threaten renal function.

C. O'Callaghan, C. Ogg, P. Andrews, 1993, BMJ.

Homozygous Familial Hypercholesterolemia: Case Series and Review of the Literature

J. Goss, A. Beiras-Fernandez, C. O’mahony, 2012, Case reports in transplantation.

Management of the diabetic patient approaching end-stage renal failure:

P. Andrews, J. Marsh, 2002 .